ACG Metals positioned for strong cash generation and long-term value as copper production ramps up, highlights DIVI fund manager 6 February 2026
Likewise’s Tony Brewer on accelerating growth, strong investment and £200m+ revenue ambition 4 February 2026
Ampeak Energy Welcomes New Strategic Shareholder in Positive Step Forward, says Longspur Research 23 February 2026
Drax Group’s Second Tolling Agreement Builds Momentum In Battery Storage, says Longspur Research 20 February 2026
Drax Group Gains Momentum as Tolling Agreement Enhances Value, Says Longspur Research 11 February 2026
Sintana Energy Strengthens Position with ExxonMobil Settlement, Eyes Growth in 2026 – Auctus Advisors LLP 4 February 2026
FTSE 100 Rises to Record on HSBC Earnings, Mining Gains Offset by Consumer Sector Weakness 25 February 2026
Vistry Group PLC (VTY.L) Stock Analysis: Navigating Challenges with Strategic Resilience 2 March 2026
PRUDENTIAL PLC ORD 5P (PRU.L) Stock Analysis: Unveiling a 19.99% Upside Potential for Investors 2 March 2026
UNITE GROUP PLC ORD 25P (UTG.L) Stock Report: Evaluating a 36.93% Potential Upside for Investors 2 March 2026
ACG Metals positioned for strong cash generation and long-term value as copper production ramps up, highlights DIVI fund manager 6 February 2026
Likewise’s Tony Brewer on accelerating growth, strong investment and £200m+ revenue ambition 4 February 2026
Ampeak Energy Welcomes New Strategic Shareholder in Positive Step Forward, says Longspur Research 23 February 2026
Drax Group’s Second Tolling Agreement Builds Momentum In Battery Storage, says Longspur Research 20 February 2026
Drax Group Gains Momentum as Tolling Agreement Enhances Value, Says Longspur Research 11 February 2026
Sintana Energy Strengthens Position with ExxonMobil Settlement, Eyes Growth in 2026 – Auctus Advisors LLP 4 February 2026
FTSE 100 Rises to Record on HSBC Earnings, Mining Gains Offset by Consumer Sector Weakness 25 February 2026
Vistry Group PLC (VTY.L) Stock Analysis: Navigating Challenges with Strategic Resilience 2 March 2026
PRUDENTIAL PLC ORD 5P (PRU.L) Stock Analysis: Unveiling a 19.99% Upside Potential for Investors 2 March 2026
UNITE GROUP PLC ORD 25P (UTG.L) Stock Report: Evaluating a 36.93% Potential Upside for Investors 2 March 2026
Edgewise Therapeutics, Inc. (EWTX) Stock Analysis: Exploring a 36% Upside Potential in the Biotechnology Sector 27 January 2026
NeoGenomics, Inc. (NEO) Stock Analysis: Exploring a 16% Potential Upside in the Diagnostics & Research Sector 27 January 2026
Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Unveiling a Potential 18.69% Upside for Investors 27 January 2026
LivaNova PLC (LIVN) Stock Analysis: Navigating Market Growth with a 13.71% Potential Upside 27 January 2026
AdaptHealth Corp. (AHCO) Stock Analysis: A 30% Upside Potential in the Healthcare Sector 27 January 2026
Veracyte, Inc. (VCYT) Stock Analysis: A Diagnostic Leader with 17.49% Potential Upside 27 January 2026
MoonLake Immunotherapeutics (MLTX) Stock Analysis: Exploring the 17% Potential Upside for Investors 27 January 2026
Twist Bioscience Corporation (TWST) Stock Analysis: Exploring the Potential of Synthetic DNA and a Strong Buy Consensus 27 January 2026
Pediatrix Medical Group, Inc. (MD) Stock Analysis: Assessing the 6.27% Potential Upside 27 January 2026
Artivion, Inc. (AORT) Stock Analysis: A 20% Upside Potential in the Medical Devices Sector 27 January 2026
Ascentage Pharma Group Internat (AAPG): Investor Outlook on a Biotech Pioneer with 78.64% Potential Upside 27 January 2026
Azenta, Inc. (AZTA) Stock Analysis: Exploring a 9% Potential Upside in the Healthcare Sector 27 January 2026
SS Innovations International (SSII) Stock Analysis: Navigating the Robotic Revolution with 192.5% Revenue Growth 27 January 2026
Recursion Pharmaceuticals, Inc. (RXRX) Stock Analysis: Exploring a 52.51% Potential Upside in Biotech 27 January 2026
Mineralys Therapeutics, Inc. (MLYS) Stock Analysis: Uncovering a 53.98% Potential Upside in Biotech 27 January 2026
ICU Medical, Inc. (ICUI) Stock Analysis: A Potential 18.3% Upside with Strong Buy Ratings 27 January 2026
Clover Health Investments, Corp (CLOV) Stock Analysis: Exploring a 29.85% Potential Upside in Healthcare Plans 27 January 2026
BioLife Solutions, Inc. (BLFS): Investor Outlook Highlights 30% Potential Upside with Strong Buy Ratings 27 January 2026
Guardian Pharmacy Services, Inc (GRDN) Stock Analysis: Unveiling a 14% Upside Potential in Healthcare 27 January 2026
The Diverse Income Trust: Why Gervais Williams Is Doubling Down on Overlooked UK Small Caps (video) 27 January 2026
Ilika plc: First Commercial Revenues Signal Pivotal Shift in Solid-State Battery Journey (Video) 26 January 2026
Ilika Plc: Solid-State Breakthroughs Put Stereax and Goliath in the Spotlight (Video) 23 January 2026
Ruffer Investment Company: Why Defence-First Investing is Winning in Volatile Markets (Video) 22 January 2026
RM plc Unlocking the Future of Global Assessment with Scalable AI and Digital Exams (Video) 21 January 2026
Croda International delivers 2025 earnings growth and targets higher margins by 2028 24 February 2026
ACG Metals positioned for strong cash generation and long-term value as copper production ramps up, highlights DIVI fund manager 6 February 2026
Likewise’s Tony Brewer on accelerating growth, strong investment and £200m+ revenue ambition 4 February 2026
Drax Group Gains Momentum as Tolling Agreement Enhances Value, Says Longspur Research 11 February 2026
Sintana Energy Strengthens Position with ExxonMobil Settlement, Eyes Growth in 2026 – Auctus Advisors LLP 4 February 2026
Ampeak Energy Welcomes New Strategic Shareholder in Positive Step Forward, says Longspur Research 23 February 2026
Drax Group’s Second Tolling Agreement Builds Momentum In Battery Storage, says Longspur Research 20 February 2026
Vistry Group PLC (VTY.L) Stock Analysis: Navigating Challenges with Strategic Resilience 2 March 2026
PRUDENTIAL PLC ORD 5P (PRU.L) Stock Analysis: Unveiling a 19.99% Upside Potential for Investors 2 March 2026
UNITE GROUP PLC ORD 25P (UTG.L) Stock Report: Evaluating a 36.93% Potential Upside for Investors 2 March 2026
